Related Experiment Video
Updated: Jul 19, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Prognostic factors in renal cell carcinoma
Brian M Shuch1, John S Lam, Arie S Belldegrun
1Department of Urology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA 90095, USA.
Seminars in Oncology
|October 19, 2006
Summary
Identifying prognostic factors for renal cell carcinoma (RCC) is crucial. Current staging systems like TNM face challenges, prompting research into new molecular markers for improved patient prognostication and targeted therapies.
Area of Science:
- Oncology
- Urology
- Medical Diagnostics
Background:
- Prognostic factor identification in renal cell carcinoma (RCC) is a growing field of research.
- The Tumor, Node, Metastasis (TNM) staging system is the current standard for RCC prognosis.
- Recent data have sparked debate regarding the adequacy of existing staging systems and the need for novel prognostic factors.
Purpose of the Study:
- To review current controversies surrounding RCC staging and prognostic factors.
- To provide an update on established and emerging prognostic modalities for RCC.
- To explore the potential impact of molecular tumor markers on future RCC staging and therapy.
Main Methods:
- Review of recent scientific literature and clinical data on RCC prognostic factors.
- Analysis of the limitations and controversies associated with current TNM staging.
- Exploration of emerging molecular markers and their potential integration into staging systems.
Main Results:
- Existing staging systems, while improved, may require further revision.
- New prognostic factors, particularly molecular markers, show promise for enhanced accuracy.
- Integrated staging systems have improved RCC prognostication, but molecular advancements are anticipated to revolutionize the field.
Conclusions:
- There is an ongoing need to refine RCC staging systems.
- Molecular tumor markers represent a significant future direction for improving RCC staging and enabling targeted therapies.
- Continued research into novel prognostic factors is essential for advancing RCC patient care.
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...